Literature DB >> 24222257

Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia.

Narinda Heyer-Chauhan, Ihinosen J Ovbude, Anne A Hills, Mark H Sullivan, Frank A Hills.   

Abstract

Glycosaminoglycans are found in extracellular matrix and on the cell surface in the form of proteoglycans. There is evidence that these molecules regulate biological processes, including cell survival, migration and angiogenesis. Preeclampsia is a common pregnancy disorder associated with insufficient placental development. This study aimed to determine the concentrations of glycosaminoglycans and the proteoglycan syndecan-1 within villous trophoblast and to investigate changes associated with preeclampsia. Seventy-five placental samples collected from third trimester singleton pregnancies were divided into term placentas following labour onset, gestational age-matched placentas prior to labour onset and preterm placentas. Preterm placentas were divided into three gestational age-matched groups, spontaneous preterm labour, preterm premature rupture of membranes (PPROM) and preterm preeclampsia. Sulphated glycosaminoglycan (sGAG) concentrations in placental extracts were quantified using a modified 1,9-dimethylmethylene blue assay. Syndecan-1 expression was localised using immunohistochemistry and concentrations in placental extracts determined by immunoassay. Preterm placentas had significantly lower sGAG concentrations compared to term tissues and concentrations were significantly lower in preeclampsia compared to spontaneous preterm labour (medians 5.80 and 10.0 μg/mg protein respectively, P<0.05). Syndecan-1 expression was localised to syncytiotrophoblast and median concentrations were lower in preeclampsia compared to PPROM material (preeclampsia median = 41.7, PPROM 74.4 ng/mg tissue) but not significantly different to concentrations in spontaneous preterm labour. Multivariate analysis revealed that decreased sGAG and syndecan-1 in preeclampsia were independent of labour, gestational age and birthweight centile. These findings may provide insights into a role for these molecules in the pathophysiology of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24222257     DOI: 10.1515/jpm-2013-0097

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  6 in total

Review 1.  A Systematic Review of Maternal Serum Syndecan-1 and Preeclampsia.

Authors:  Kitty George; Prakar Poudel; Roopa Chalasani; Mastiyage R Goonathilake; Sara Waqar; Sheeba George; Wilford Jean-Baptiste; Amina Yusuf Ali; Bithaiah Inyang; Feeba Sam Koshy; Lubna Mohammed
Journal:  Cureus       Date:  2022-06-09

Review 2.  Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas.

Authors:  Orsolya Oravecz; Andrea Balogh; Roberto Romero; Yi Xu; Kata Juhasz; Zsolt Gelencser; Zhonghui Xu; Gaurav Bhatti; Roger Pique-Regi; Balint Peterfia; Petronella Hupuczi; Ilona Kovalszky; Padma Murthi; Adi L Tarca; Zoltan Papp; Janos Matko; Nandor Gabor Than
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

3.  Decidualization and syndecan-1 knock down sensitize endometrial stromal cells to apoptosis induced by embryonic stimuli.

Authors:  Sarah Jean Boeddeker; Dunja Maria Baston-Buest; Tanja Fehm; Jan Kruessel; Alexandra Hess
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

4.  Epigenetic regulation of placental gene expression in transcriptional subtypes of preeclampsia.

Authors:  Katherine Leavey; Samantha L Wilson; Shannon A Bainbridge; Wendy P Robinson; Brian J Cox
Journal:  Clin Epigenetics       Date:  2018-03-02       Impact factor: 6.551

Review 5.  Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?

Authors:  Marina M Ziganshina; Ekaterina L Yarotskaya; Nicolai V Bovin; Stanislav V Pavlovich; Gennady T Sukhikh
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

6.  Low Soluble Syndecan-1 Precedes Preeclampsia.

Authors:  Robin E Gandley; Andrew Althouse; Arundhathi Jeyabalan; Julia M Bregand-White; Stacy McGonigal; Ashley C Myerski; Marcia Gallaher; Robert W Powers; Carl A Hubel
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.